首页|丁丙诺啡在癌性疼痛应用上的临床观察

丁丙诺啡在癌性疼痛应用上的临床观察

扫码查看
目的:本研究旨在探讨盐酸丁丙诺啡注射液控制癌性疼痛的有效性和安全性。方法:选取2013年12月~2014年12月于我院就诊的70例伴有中重度癌痛的晚期恶性肿瘤患者,根据随机分组原则将患者分成观察组(35例)和对照组(35例)。对照组患者癌痛发作时给予盐酸吗啡注射液治疗,观察组患者给予盐酸丁丙诺啡注射液治疗。连续用药1周为一疗程,对比两组患者疼痛控制效果及用药不良反应。结果:两组患者用药后临床疗效均较好,但观察组镇痛疗效好于对照组(P<0.05)。观察组发生不良反应发生率显著少于对照组(P<0.05)。结论:丁丙诺啡及吗啡用于控制中晚期恶性肿瘤患者癌痛均有明显效果,丁丙诺啡镇痛效果优于吗啡,且不良反应较少,用法简便,值得在癌性疼痛治疗工作中加以推广。
Objective: To Investigate the efficacy and safety of buprenorphine hydrochloride injection in treatment of cancer pain. Methods:70 advanced malignant tumor patients with moderate or severe cancer pain were enrolled in our hospital. They were divided into two groups:observation group ( 35 cases) and control group ( 35 cases). Patients in the control group were treated with morphine hydrochloride injection, and the observation group was treated with buprenorphine hydrochloride injection. The course of treatment was 1 week. The analgesic effect and adverse drug reaction were compared between two groups. Results: The analgesic effect of the observation group was better than the control group (P<0.05). The number of patients in observation group with adverse reactions were significantly less than that of the control group (P<0.05). Conclusion:It has obvious effect of buprenorphine and morphine in treatment of cancer pain. The analgesic effect of buprenorphine is better than that of morphine, and it has less adverse reactions. It is worth to be popularized in treatment of cancer pain.

buprenorphinecancer paincancerinjectionsafety

刘刚、蒋顺

展开 >

桂林市全州县人民医院内三科 广西省桂林市 541500

丁丙诺啡 癌性疼痛 恶性肿瘤 注射 安全性

2015

延边医学

延边医学

ISSN:
年,卷(期):2015.(7)
  • 1
  • 6